IncomeSharks
IncomeSharks
IncomeSharks avatar

IncomeSharks

Sign up
Stock
Crypto
Macro

Crypto and stock trader focused on fundamental analysis, trend analysis, and swing trading.

918Posts
1.7kComments
81%Best ROI
joined

Joined on 13th October 2025

IncomeSharks
Apr 26, 2026Public Post
Healthcare a lagging sector that should see rotation Energy started the year off as the hot sector, Tech/AI had a big correction, and now it's rebounding. Still cautious on the move because they were overvalued before the dip, and now are at higher valuations. The market is really trying to stick to a narrative to push higher and I'm not trying to short the strength as it can last irrationally longer than it should. My mindset is usually to find what's next, and sometimes it works very well, other times it's annoying missing some hot trends. I chose to be conservative and play it safe instead of gambling on the AI/Tech rebound so missed out on the move. So I either can sulk for months and try FOMO chasing what's already popped or remain patient and look for the next round of winners and win back some skeptics. A good example was bidding $INTC sub $20 and catching the first massive rally off of the move. While I was waiting for that one $NVDA and other AI stocks were red hot and runn ... see more
Healthcare a lagging sector that should see rotation Energy started the year off as the hot sector, Tech/AI had a big correction, and now it's rebounding. Still cautious on the move because they were overvalued before the dip, and now are at higher valuations. The market is really trying to stick to a narrative to push higher and I'm not trying to short the strength as it can last irrationally longer than it should. My mindset is usually to find what's next, and sometimes it works very well, other times it's annoying missing some hot trends. I chose to be conservative and play it safe instead of gambling on the AI/Tech rebound so missed out on the move. So I either can sulk for months and try FOMO chasing what's already popped or remain patient and look for the next round of winners and win back some skeptics. A good example was bidding $INTC sub $20 and catching the first massive rally off of the move. While I was waiting for that one $NVDA and other AI stocks were red hot and running. I remained patient, and ended up returning triple digits which was a larger move then the hot ones. In a perfect world should I have rode up what was hot, and rotated back? Absolutely. But would I have missed having exposure before the government announced the $INTC investment, 100%. So now to dig deep into some Healtchare plays that are leveraging AI and are showing YOY growth on healthy corrections. Earnings coming up so watching closely. $TEMP - Is an AI-driven precision medicine company focused on oncology and broader healthcare data platforms. On a 50% correction, possible support/diagonal breakout 2025 Revenue at 1.3 billion (83% YOY) Q4 2025: 367 million 2026 Estimate: 1.59 billion (25% YOY) 20227 Estimate: 1.94 billion (22% YOY) https://www.tradingview.com/x/OLTIdd5x/ $GRAL - Early cancer detection blood test. Had a great 4x run on this one last time. The results of one study caused a sell off but it seems they have more coming and overall could be another opportunity to ride this one back up. Kind of waiting more for confirmation on earnings though or price to break out. Total Revenue: $147.2M (+17% YoY from $125.6M) 2026 Revenue Estimates: $183M total revenue (+24.5% YoY consensus) 2027 Revenue Estimate: $232M (+26%+ YoY from 2026 estimates) https://www.tradingview.com/x/ktHh1yhm/ $WGS - AI powered genome sequencing for rare/pediatric diseases and cancer. 2 billion marketcap play so a little more risky but higher upside potential. 2025 Revenue - 427.5 million (41% YOY) 2026 YoY Growth: 33%, First positive adjusted net income expected 2027 YOY Growth: Around 20%, expansion into new specialties https://www.tradingview.com/x/fDG69Gz2/ Waiting for earnings on at least one of these to see if sentiment and numbers are gaining momentum.Healthcare a lagging sector that should see rotation Energy started the year off as the hot sector, Tech/AI had a big correction, and now it's rebounding. Still cautious on the move because they were overvalued before the dip, and now are at higher valuations. The market is really trying to stick to a narrative to push higher and I'm not trying to short the strength as it can last irrationally longer than it should. My mindset is usually to find what's next, and sometimes it works very well, other times it's annoying missing some hot trends. I chose to be conservative and play it safe instead of gambling on the AI/Tech rebound so missed out on the move. So I either can sulk for months and try FOMO chasing what's already popped or remain patient and look for the next round of winners and win back some skeptics. A good example was bidding $INTC sub $20 and catching the first massive rally off of the move. While I was waiting for that one $NVDA and other AI stocks were red hot and running. I remained patient, and ended up returning triple digits which was a larger move then the hot ones. In a perfect world should I have rode up what was hot, and rotated back? Absolutely. But would I have missed having exposure before the government announced the $INTC investment, 100%. So now to dig deep into some Healtchare plays that are leveraging AI and are showing YOY growth on healthy corrections. Earnings coming up so watching closely. $TEMP - Is an AI-driven precision medicine company focused on oncology and broader healthcare data platforms. On a 50% correction, possible support/diagonal breakout 2025 Revenue at 1.3 billion (83% YOY) Q4 2025: 367 million 2026 Estimate: 1.59 billion (25% YOY) 20227 Estimate: 1.94 billion (22% YOY) https://www.tradingview.com/x/OLTIdd5x/ $GRAL - Early cancer detection blood test. Had a great 4x run on this one last time. The results of one study caused a sell off but it seems they have more coming and overall could be another opportunity to ride this one back up. Kind of waiting more for confirmation on earnings though or price to break out. Total Revenue: $147.2M (+17% YoY from $125.6M) 2026 Revenue Estimates: $183M total revenue (+24.5% YoY consensus) 2027 Revenue Estimate: $232M (+26%+ YoY from 2026 estimates) https://www.tradingview.com/x/ktHh1yhm/ $WGS - AI powered genome sequencing for rare/pediatric diseases and cancer. 2 billion marketcap play so a little more risky but higher upside potential. 2025 Revenue - 427.5 million (41% YOY) 2026 YoY Growth: 33%, First positive adjusted net income expected 2027 YOY Growth: Around 20%, expansion into new specialties https://www.tradingview.com/x/fDG69Gz2/ Waiting for earnings on at least one of these to see if sentiment and numbers are gaining momentum.Healthcare a lagging sector that should see rotation Energy started the year off as the hot sector, Tech/AI had a big correction, and now it's rebounding. Still cautious on the move because they were overvalued before the dip, and now are at higher valuations. The market is really trying to stick to a narrative to push higher and I'm not trying to short the strength as it can last irrationally longer than it should. My mindset is usually to find what's next, and sometimes it works very well, other times it's annoying missing some hot trends. I chose to be conservative and play it safe instead of gambling on the AI/Tech rebound so missed out on the move. So I either can sulk for months and try FOMO chasing what's already popped or remain patient and look for the next round of winners and win back some skeptics. A good example was bidding $INTC sub $20 and catching the first massive rally off of the move. While I was waiting for that one $NVDA and other AI stocks were red hot and running. I remained patient, and ended up returning triple digits which was a larger move then the hot ones. In a perfect world should I have rode up what was hot, and rotated back? Absolutely. But would I have missed having exposure before the government announced the $INTC investment, 100%. So now to dig deep into some Healtchare plays that are leveraging AI and are showing YOY growth on healthy corrections. Earnings coming up so watching closely. $TEMP - Is an AI-driven precision medicine company focused on oncology and broader healthcare data platforms. On a 50% correction, possible support/diagonal breakout 2025 Revenue at 1.3 billion (83% YOY) Q4 2025: 367 million 2026 Estimate: 1.59 billion (25% YOY) 20227 Estimate: 1.94 billion (22% YOY) https://www.tradingview.com/x/OLTIdd5x/ $GRAL - Early cancer detection blood test. Had a great 4x run on this one last time. The results of one study caused a sell off but it seems they have more coming and overall could be another opportunity to ride this one back up. Kind of waiting more for confirmation on earnings though or price to break out. Total Revenue: $147.2M (+17% YoY from $125.6M) 2026 Revenue Estimates: $183M total revenue (+24.5% YoY consensus) 2027 Revenue Estimate: $232M (+26%+ YoY from 2026 estimates) https://www.tradingview.com/x/ktHh1yhm/ $WGS - AI powered genome sequencing for rare/pediatric diseases and cancer. 2 billion marketcap play so a little more risky but higher upside potential. 2025 Revenue - 427.5 million (41% YOY) 2026 YoY Growth: 33%, First positive adjusted net income expected 2027 YOY Growth: Around 20%, expansion into new specialties https://www.tradingview.com/x/fDG69Gz2/ Waiting for earnings on at least one of these to see if sentiment and numbers are gaining momentum.
IncomeSharks
Apr 20, 2026Public Post
Sunday Slice Report Wild week for stocks which saw a massive 2 week long rally continue with stock market all time highs for the S&P 500 NASDAQ went up 6.5% and the S&P 500 up 4.5% making it now up on the year Geopolitical tensions took a break and the Strait of Hormuz was opened Friday which saw $OIL go lower and the markets push up (now during the weekend it's closed again) Crypto saw some life again, but once again was the punching bag for news as a lot of the gains erased or pushed back Futures opening up red but hard to know what it will be like until the stock market actually opens Planned Events Pretty boring week for economic data and planned events. A jobless claims (April 23rd) and some data like pending home sales and US retail sales. Then a Consumer Sentiment comes out. So while the markets probably won't be boring or slow there's nothing really happening in "planned" stuff. Earnings Week We are now back into earnings season again so we are going to see some more volatil ... see more